Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro

Cervical cancer ranks as the fourth most prevalent cancer globally and in Asia, standing as the second most common in Indonesia. Despite its efficacy, doxorubicin chemotherapy is associated with significant side effects. To mitigate these adverse effects, a promising approach involves combining conv...

Full description

Saved in:
Bibliographic Details
Main Authors: Windy Aristiani, Widea Rossi Desvita, Dika Khayatulisma, Citra Ariani Edityaningrum, Any Guntarti, Laela Hayu Nurani
Format: Article
Language:English
Published: LPPT Universitas Gadjah Mada 2024-04-01
Series:Journal of Food and Pharmaceutical Sciences
Subjects:
Online Access:https://jurnal.ugm.ac.id/v3/JFPS/article/view/10887/4122
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589746902138880
author Windy Aristiani
Widea Rossi Desvita
Dika Khayatulisma
Citra Ariani Edityaningrum
Any Guntarti
Laela Hayu Nurani
author_facet Windy Aristiani
Widea Rossi Desvita
Dika Khayatulisma
Citra Ariani Edityaningrum
Any Guntarti
Laela Hayu Nurani
author_sort Windy Aristiani
collection DOAJ
description Cervical cancer ranks as the fourth most prevalent cancer globally and in Asia, standing as the second most common in Indonesia. Despite its efficacy, doxorubicin chemotherapy is associated with significant side effects. To mitigate these adverse effects, a promising approach involves combining conventional drugs with curcumin. Both curcumin and doxorubicin have demonstrated cytotoxic effects against cervical cancer (HeLa). This research aims to determine the synergistic effect of the combination of doxorubicin and curcumin on HeLa and safety in normal cells (Vero cells). This study adopted an experimental design utilizing doxorubicin and curcumin samples with HeLa and Vero cells. The investigation was initiated with cytotoxic and combination tests using the MTT method. The obtained results included IC50 values and combination indices, and the analysis involved a comparative examination of outcomes between HeLa and Vero cells. Cytotoxic tests revealed IC50 values for doxorubicin and curcumin on HeLa cells, measured in 2,17 ± 0,06 and 26,37 ± 2,00 µg/mL, and 17,32 ± 1,99 and 181,88 ± 30,48 µg/mL on Vero cells. Combination test results were represented by combination index . The synergistic effect is observed at the combination of curcumin at a concentration of 9 μg/mL and doxorubicin at a concentration of 0,125 μg/mL, resulting in a combination index of 0,50. These findings suggest a promising avenue for enhancing the therapeutic potential of doxorubicin in cervical cancer treatment while minimizing adverse effects.
format Article
id doaj-art-10f28c4c6e8f4b988813efe8e59c7e1a
institution Kabale University
issn 2089-7200
2339-0948
language English
publishDate 2024-04-01
publisher LPPT Universitas Gadjah Mada
record_format Article
series Journal of Food and Pharmaceutical Sciences
spelling doaj-art-10f28c4c6e8f4b988813efe8e59c7e1a2025-01-24T08:46:05ZengLPPT Universitas Gadjah MadaJournal of Food and Pharmaceutical Sciences2089-72002339-09482024-04-01121526010.22146/jfps.10887Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in VitroWindy Aristiani0Widea Rossi Desvita1Dika Khayatulisma2Citra Ariani Edityaningrum3Any Guntarti4Laela Hayu Nurani5Faculty of Medicine, Ahmad Dahlan University, Yogyakarta, IndonesiaFaculty of Medicine, Ahmad Dahlan University, Yogyakarta, IndonesiaFaculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, IndonesiaFaculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, IndonesiaFaculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, IndonesiaFaculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, IndonesiaCervical cancer ranks as the fourth most prevalent cancer globally and in Asia, standing as the second most common in Indonesia. Despite its efficacy, doxorubicin chemotherapy is associated with significant side effects. To mitigate these adverse effects, a promising approach involves combining conventional drugs with curcumin. Both curcumin and doxorubicin have demonstrated cytotoxic effects against cervical cancer (HeLa). This research aims to determine the synergistic effect of the combination of doxorubicin and curcumin on HeLa and safety in normal cells (Vero cells). This study adopted an experimental design utilizing doxorubicin and curcumin samples with HeLa and Vero cells. The investigation was initiated with cytotoxic and combination tests using the MTT method. The obtained results included IC50 values and combination indices, and the analysis involved a comparative examination of outcomes between HeLa and Vero cells. Cytotoxic tests revealed IC50 values for doxorubicin and curcumin on HeLa cells, measured in 2,17 ± 0,06 and 26,37 ± 2,00 µg/mL, and 17,32 ± 1,99 and 181,88 ± 30,48 µg/mL on Vero cells. Combination test results were represented by combination index . The synergistic effect is observed at the combination of curcumin at a concentration of 9 μg/mL and doxorubicin at a concentration of 0,125 μg/mL, resulting in a combination index of 0,50. These findings suggest a promising avenue for enhancing the therapeutic potential of doxorubicin in cervical cancer treatment while minimizing adverse effects.https://jurnal.ugm.ac.id/v3/JFPS/article/view/10887/4122antiproliferativecancercervicalcombinationdoxorubicin
spellingShingle Windy Aristiani
Widea Rossi Desvita
Dika Khayatulisma
Citra Ariani Edityaningrum
Any Guntarti
Laela Hayu Nurani
Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
Journal of Food and Pharmaceutical Sciences
antiproliferative
cancer
cervical
combination
doxorubicin
title Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
title_full Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
title_fullStr Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
title_full_unstemmed Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
title_short Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
title_sort enhancing anticancer potential investigating the synergistic impact of doxorubicin and curcumin on hela and vero cells in vitro
topic antiproliferative
cancer
cervical
combination
doxorubicin
url https://jurnal.ugm.ac.id/v3/JFPS/article/view/10887/4122
work_keys_str_mv AT windyaristiani enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro
AT widearossidesvita enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro
AT dikakhayatulisma enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro
AT citraarianiedityaningrum enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro
AT anyguntarti enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro
AT laelahayunurani enhancinganticancerpotentialinvestigatingthesynergisticimpactofdoxorubicinandcurcuminonhelaandverocellsinvitro